Quinacrine acts as a slow, voltage-dependent blocker of open end-plate channels at the frog neuromuscular junction.
No takes yet. Share an insight, caveat, or question.
Quinacrine's open-channel blockade at frog junctions merits mechanistic follow-up; leaves open relevance to mammalian or human neuromuscular function.
Adams et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: